Oda K, Miki K, Hirose S, Takami N, Misumi Y, Ikehara Y
J Biochem. 1986 Dec;100(6):1669-75. doi: 10.1093/oxfordjournals.jbchem.a121876.
Using an immunoblotting technique, we have studied the processing of plasma proteins in subcellular fractions of rat liver including rough and smooth microsomes and the Golgi subfractions. Each subcellular fraction was directly subjected to SDS-polyacrylamide gel electrophoresis and analyzed by immunoblotting with antibodies against alpha 1-protease inhibitor, haptoglobin, and the third component of complement (C3) in combination with 125I-protein A or 125I-rabbit anti-(goat IgG)-IgG. The results demonstrated that proteolytic processing of precursors of complement C3 and haptoglobin occurs in different compartments along the secretory pathway; conversion of prohaptoglobin takes place in the endoplasmic reticulum, while that of pro-C3 occurs in the Golgi complex. The processing in oligosaccharide chains of glycoproteins was also analyzed. The Golgi fraction was characterized by the presence of the mature 56 kDa alpha 1-protease inhibitor, which was indistinguishable from the serum alpha 1-protease inhibitor in SDS-polyacrylamide gel electrophoresis. In contrast, the immature 51 kDa form was the only form of alpha 1-protease inhibitor found in the microsomal fraction. Similar results were obtained for the beta subunit of haptoglobin; the immature 33 kDa form was detected in the microsomal fraction, while the mature 36 kDa form was found in the Golgi fraction. Taken together, these results identified the intracellular sites where these plasma proteins are modified by selective proteolysis and/or glycosylation.
我们运用免疫印迹技术,研究了大鼠肝脏亚细胞组分(包括粗面和滑面微粒体以及高尔基体亚组分)中血浆蛋白的加工过程。每个亚细胞组分直接进行十二烷基硫酸钠 - 聚丙烯酰胺凝胶电泳,并结合¹²⁵I - 蛋白A或¹²⁵I - 兔抗(山羊IgG)- IgG,用抗α1 - 蛋白酶抑制剂、触珠蛋白和补体第三成分(C3)的抗体进行免疫印迹分析。结果表明,补体C3和触珠蛋白前体的蛋白水解加工发生在分泌途径的不同区室;触珠蛋白原的转化发生在内质网,而C3原的转化发生在高尔基体复合体。我们还分析了糖蛋白寡糖链的加工过程。高尔基体组分的特征是存在成熟的56 kDaα1 - 蛋白酶抑制剂,其在十二烷基硫酸钠 - 聚丙烯酰胺凝胶电泳中与血清α1 - 蛋白酶抑制剂无法区分。相比之下,未成熟的51 kDa形式是微粒体组分中发现的α1 - 蛋白酶抑制剂的唯一形式。触珠蛋白的β亚基也得到了类似结果;在微粒体组分中检测到未成熟的33 kDa形式,而在高尔基体组分中发现了成熟的36 kDa形式。综上所述,这些结果确定了这些血浆蛋白通过选择性蛋白水解和/或糖基化进行修饰的细胞内位点。